US2014121121A1PendingUtilityA1
System and method for determining individualized medical intervention for a disease state
Est. expiryMay 18, 2026(expired)· nominal 20-yr term from priority
G01N 33/57585G01N 33/575C12Q 1/6886G16B 25/00G16B 20/00G01N 2333/91205G16H 15/00G16B 50/00C12Q 2600/158C12Q 1/6883G01N 2333/914G16H 50/20G01N 2333/71C12Q 2600/106G01N 33/6893G16H 20/30G16B 25/10G16B 20/20G16B 50/10G16H 10/40G16H 20/10G16H 70/20G06F 19/18
64
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A system and method for determining individualized medical intervention for a particular disease state, and especially for cancers, that includes the molecular profiling of a biological sample from the patient, determining whether any molecular findings including one or more genes, one or more gene expressed proteins, one or more molecular mechanisms, and/or combinations of such exhibit a change in expression compared to a reference, and identifying a non-specific disease therapy or agent capable of interacting with the genes, gene expressed proteins, molecular mechanisms, or combinations of such molecular findings that exhibited a change in expression.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A system for generating a report identifying a therapeutic agent for an individual with a cancer comprising:
a. one or more computer database comprising:
i. a reference value for a plurality of molecular targets;
ii. a listing of available therapeutic agents for said plurality of molecular targets;
b. a computer-readable program code for inputting individualized molecular profile test values for the plurality of molecular targets in the individual and comparing said test values with a corresponding reference value in (a)(i), and identifying any molecular targets whose test value is changed as compared to said reference value in (a)(i); c. a computer-readable program code for accessing the database in (a) and identifying one or more therapeutic agent in (a)(ii) for the molecular targets having a change identified in (b); and d. a computer-readable program for generating a report that comprises a listing of at least one molecular target exhibiting a change in (b) and the one or more therapeutic agent identified for the molecular targets having a change.
2 . The system of claim 1 , wherein the inputting in (b) is performed from a location that is remote from said database in (a).
3 . The system of claim 1 , wherein the inputting is performed over an internet connection.
4 . The system of claim 1 , wherein the report is in electronic or paper format.
5 . The system of claim 1 , wherein the one or more computer database further comprise data corresponding to one or more clinical trial of a molecular target.
6 . The system of claim 1 , wherein the reference value for each of the plurality of molecular targets comprises a nucleic acid and/or protein.
7 . The system of claim 1 , wherein the testing of the molecular target is performed after the individual has received drug therapy for the cancer.
8 . The system of claim 1 , wherein the molecular profile comprises assessing a cell, tissue sample, blood sample or combination thereof.
9 . The system of claim 1 , wherein the molecular profiling comprises performing a test for a gene and/or protein.
10 . The system of claim 1 , wherein the reference is obtained from one or more normal individual without the cancer.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.